Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.
Recent News
Can immunotherapy improve the treatment of advanced neuroendocrine neoplasms?
Reporting from #ESMO2021 Can immunotherapy improve treatment of advanced #Neuroendocrine neoplasms? SELECT HERE TO READ REPORT.
Invest urgently in the NHS cancer workforce Petition
Invest urgently in the NHS cancer workforce in the autumn Spending Review Covid-19 exposed the terrible strain the NHS cancer workforce has been under for years. This is now the greatest threat facing the NHS. We are calling for the Government to use the Spending...
Research & You
Undertaking research - whether through clinical trials or gathering data - is vital to improving both care and quality of life for those living with Neuroendocrine Cancer. At NCUK we are proud to have driven or been involved in a number of research projects both...